Periconceptional Folic Acid Supplementation and the Risk of Preeclampsia in Eastern Sudan: An Unmatched Case-Control Study
International Journal of Women's Health · 2026-01 · Volume 18 · 1-10
DOI: 10.2147/ijwh.s567668 ↗Kurz gefasst
Fall-Kontroll-Studie in der Zeitschrift International Journal of Women's Health, 2026-01. Verfasst von Gamal K Adam und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Gadarif University, Gadarif, Sudan. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Purpose
This study aimed to investigate the association between periconceptional [before conception/pregnancy (preconception) through the first trimester (around 10-14 weeks)] folic acid supplementation and the risk of preeclampsia among pregnant women in Gadarif, eastern Sudan.
Methods
This was an unmatched case-control study (127 cases and 127 controls) conducted in 2024 at Gadarif Maternity Hospital in Gadarif, Eastern Sudan. The cases were pregnant women diagnosed with preeclampsia, while the controls were pregnant women without preeclampsia. Participants' sociodemographic and obstetrical data were assessed via a questionnaire. Multivariate binary analyses were also performed.
Results
Women with preeclampsia were less likely to have used periconceptional folic acid supplementation (12 [9.4%]26 vs [20.5%], p = 0.016). The univariate binary analysis showed that maternal age, gravidity, overweight/obesity, and periconceptional folic acid supplementation were significantly associated with preeclampsia. However, residence, internal displacement, couples' education, maternal occupation, maternal blood group, antenatal care, anemia, and number of fetuses in the current pregnancy were not associated with preeclampsia. The multivariate binary analysis showed that primigravida (adjusted odds ratio, AOR = 6.20, 95% confidence interval, CI 3.16-12.14), not taking periconceptional folic acid supplementation (AOR = 2.24, 95% CI 1.02-4.96), and being anemic (AOR = 1.94, 95% CI 1.10-3.40) were associated with an increased risk of preeclampsia. However, maternal age and being overweight or obese were confounding factors.
Conclusion
This study provides compelling evidence that periconceptional folic acid supplementation is significantly associated with a reduced risk of preeclampsia in eastern Sudan. It also reinforces the importance of primigravida and anemia as critical risk factors. These findings have direct public health implications, including intensified efforts to promote early, consistent folic acid supplementation, alongside targeted interventions for primigravid women and anemia management, to improve maternal and child health outcomes in the region.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine, Gadarif University, Gadarif, Sudan.
- Department of Obstetrics and Gynecology, College of Medicine, Qassim University, Buraydah, Saudi Arabia.
ORCID-Profile: Ishag Adam
Zitieren
APA
Adam, G. K., AlHabardi, N., & Adam, I. (2026). Periconceptional Folic Acid Supplementation and the Risk of Preeclampsia in Eastern Sudan: An Unmatched Case-Control Study. International Journal of Women's Health, Volume 18, 1-10. https://doi.org/10.2147/ijwh.s567668
Vancouver
Adam GK, AlHabardi N, Adam I. Periconceptional Folic Acid Supplementation and the Risk of Preeclampsia in Eastern Sudan: An Unmatched Case-Control Study. International Journal of Women's Health. 2026;Volume 18:1-10. doi:10.2147/ijwh.s567668
BibTeX
@article{Adam2026,
author = {Adam, Gamal K and AlHabardi, Nadiah and Adam, Ishag},
title = {Periconceptional Folic Acid Supplementation and the Risk of Preeclampsia in Eastern Sudan: An Unmatched Case-Control Study},
journal = {International Journal of Women's Health},
year = {2026},
volume = {Volume 18},
pages = {1--10},
doi = {10.2147/ijwh.s567668}
}
EUVIMED